The Obeticholic Acid Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Obeticholic Acid Market?
The market size of obeticholic acid has seen significant growth recently. It is predicted to expand from $0.90 billion in 2024 to $1.02 billion in 2025, with a compound annual growth rate (CAGR) of 13.4%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Obeticholic Acid Industry?
The obeticholic acid market is projected to reach $1.67 billion in 2029, growing at a compound annual growth rate (CAGR) of 13.1%.
Download Your Free Sample of the 2025 Obeticholic Acid Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Obeticholic Acid Market?
The key drivers in the obeticholic acid market are:
• Rising prevalence of Primary Biliary Cholangitis (PBC) and Non-Alcoholic Steatohepatitis (NASH)
• Increased demand for innovative treatment methods for liver diseases
• Enhanced awareness and understanding of liver diseases and their potential treatments
• Expansion of healthcare access in emerging markets
Global Market Segmentation: Identifying Major Obeticholic Acid Industry Segments
The obeticholic acid market covered in this report is segmented –
1) By Product Type: Tablets, Capsules, Other Product Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications
Subsegmentss:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets
2) By Capsules: Soft Gelatin Capsules, Hard Gelatin Capsules
3) By Other Product Types: Oral Suspensions, Injectable Formulations
Pre-order the 2025 Obeticholic Acid Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Obeticholic Acid Market?
The key trends in the obeticholic acid market are:
• The increasing prevalence of primary biliary cholangitis (PBC) and non-alcoholic steatohepatitis (NASH) is shaping the obeticholic acid market's future.
• Demand for innovative liver disease treatments is becoming a significant emerging trend.
• Integration of digital health tools for enhanced monitoring and compliance is becoming increasingly influential.
• Advances in liver disease biomarkers and diagnostic technologies are emerging as an influential trend in the market development.
Who Are the Top Competitors & Leading Players in the Obeticholic Acid Market?
Major players in the obeticholic acid market are:
• Pfizer Inc.
• GlaxoSmithKline (GSK)
• Gilead Sciences Inc.
• Amgen Inc.
• Genfit
• Teva Pharmaceutical Industries Ltd.
• Regeneron Pharmaceuticals
• WuXi AppTec
• Bayer AG
• Sumitomo Dainippon Pharma Co. Ltd.
• Horizon Therapeutics
• Dr. Reddy’s Laboratories
• Lupin Limited
• Hepalink Pharmaceutical Group5
• Alembic Pharmaceuticals
• Intercept Pharmaceuticals Inc.
• Enanta Pharmaceuticals
• Viva Life sciences
• Omgene Life Sciences Pvt. Ltd.
• Zydus Cadila
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the Obeticholic Acid market in 2024
